NCT04971473View on ClinicalTrials.gov

Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal

PHASE3CompletedINTERVENTIONAL

Enrollment

201

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

July 5, 2023

Study Completion Date

July 5, 2023

Conditions

Differentiated Thyroid Cancer

Interventions

BIOLOGICAL

rhTSH

Scanning was done 48 hours after the radioiodine administration. Each patient was scanned first following rhTSH and then scanned after thyroid hormone withdrawal.

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY

NCT04971473 - Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal | Biotech Hunter | Biotech Hunter